In fact, silencing the Sp1 gene by small interfering RNA (siRNA) resulted in a 75% decrease in the responsiveness of the human APP promoter and SP1 and Aβ being co-localized in brains of AD patients [39,40]. The gene discussed is APP; the disease is Alzheimer disease.